Antiresorptives: Safety Concerns-Clinical Perspective. [electronic resource]
Producer: 20180724Description: 859-863 p. digitalISSN:- 1533-1601
- Antibodies, Monoclonal, Humanized -- adverse effects
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- pathology
- Bone Density Conservation Agents -- adverse effects
- Bone Remodeling -- drug effects
- Clinical Trials, Phase III as Topic
- Denosumab -- adverse effects
- Diphosphonates -- adverse effects
- Female
- Femoral Fractures -- chemically induced
- Humans
- Incidence
- Observational Studies as Topic
- Osteoporosis -- drug therapy
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.